Skip to main content
. 2021 Feb 17;10:625911. doi: 10.3389/fonc.2020.625911

Figure 2.

Figure 2

PFS in patients with high and low levels of plasma IL-8 (A) and ICAM-1 (B). PFS was defined as the time from the first day of radiotherapy to the date of any progression, death, and loss to follow-up. Patients were censored at the last follow-up if no progression or death occurred.